Earendil Labs Announces Research Collaboration with Genentech to Discover and Develop Therapeutic Bispecific Antibodies in Oncology
WILMINGTON, Del., Sept. 24, 2026 /PRNewswire/ -- Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research collaboration with Genentech, a member of the Roche Group, to discover and develop multiple therapeutic bispecific antibody...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- CGTN: Proč svět sleduje setkání Si Ťin-pchinga a Donalda Trumpa - směřování čínsko-amerických vztahů, utváření budoucnosti
- iQIYI iJOY Conference 2026: Expanding Its Premium Slate with 350+ New Titles and Entering a New Chapter for AI-Powered Entertainment
- Mid-Autumn Festival: Exploring Ancient Rituals at the Temple of the Moon, Expressing Good Wishes Beneath the Full Moon
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →